# Avencell

**Canonical:** https://apis.io/providers/avencell/  
**Website:** https://equityzen.com/company/avencell  
**APIs profiled:** 0

Avencell develops next‑generation immunotherapies, focusing on powerful, targeted, and safe CAR‑T cell platforms. Their proprietary switchable CAR technology enables precise control of T‑cell activity, improving therapeutic windows and reducing side effects. Avencell aims to overcome limitations of current cell therapies to treat hard‑to‑treat cancers worldwide.

## Kin Score — 2.6 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 2.6).

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Tags

Biotechnology, Immunotherapy, CAR-T, Healthcare, Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/avencell/). Scores are computed from the provider's own public artifacts under a published rubric.